Atul Saran is EVP, Chief Strat & Dev Officer of Emergent BioSolutions Inc.. Currently has a direct ownership of 86,645 shares of EBS, which is worth approximately $719,153. The most recent transaction as insider was on Feb 28, 2023, when has been sold 971 shares (Common Stock) at a price of $12.38 per share, resulting in proceeds of $12,020. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 86.6K
0% 3M change
0% 12M change
Total Value Held $719,153

ATUL SARAN Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 28 2023
SELL
Payment of exercise price or tax liability
$12,020 $12.38 p/Share
971 Reduced 1.11%
86,645 Common Stock
Feb 24 2023
SELL
Payment of exercise price or tax liability
$11,584 $13.71 p/Share
845 Reduced 0.96%
87,616 Common Stock
Feb 23 2023
SELL
Payment of exercise price or tax liability
$5,219 $14.3 p/Share
365 Reduced 0.41%
88,461 Common Stock
Feb 08 2023
SELL
Payment of exercise price or tax liability
$27,175 $13.25 p/Share
2,051 Reduced 2.26%
88,826 Common Stock
Feb 08 2023
BUY
Grant, award, or other acquisition
-
95 Added 0.1%
90,877 Common Stock
Mar 01 2022
BUY
Grant, award, or other acquisition
-
48,333 Added 34.55%
91,546 Common Stock
Feb 28 2022
SELL
Payment of exercise price or tax liability
$30,285 $39.64 p/Share
764 Reduced 0.83%
90,782 Common Stock
Feb 24 2022
SELL
Payment of exercise price or tax liability
$36,397 $42.47 p/Share
857 Reduced 1.94%
43,213 Common Stock
Feb 23 2022
SELL
Payment of exercise price or tax liability
$18,666 $42.23 p/Share
442 Reduced 0.99%
44,070 Common Stock
Feb 22 2022
SELL
Payment of exercise price or tax liability
$88,007 $42.23 p/Share
2,084 Reduced 4.47%
44,512 Common Stock
Feb 22 2022
BUY
Grant, award, or other acquisition
-
1,836 Added 3.79%
46,596 Common Stock
Feb 26 2021
SELL
Payment of exercise price or tax liability
$151,845 $97.15 p/Share
1,563 Reduced 3.37%
44,760 Common Stock
Feb 24 2021
SELL
Payment of exercise price or tax liability
$82,926 $93.49 p/Share
887 Reduced 1.88%
46,323 Common Stock
Feb 24 2021
BUY
Grant, award, or other acquisition
-
7,488 Added 13.69%
47,210 Common Stock
Feb 09 2021
SELL
Payment of exercise price or tax liability
$299,983 $123.45 p/Share
2,430 Reduced 5.76%
39,722 Common Stock
Feb 09 2021
BUY
Grant, award, or other acquisition
-
2,656 Added 5.93%
42,152 Common Stock
AS

Atul Saran

EVP, Chief Strat & Dev Officer
Gaithersburg, MD

Track Institutional and Insider Activities on EBS

Follow Emergent BioSolutions Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells EBS shares.

Notify only if

Insider Trading

Get notified when an Emergent Bio Solutions Inc. insider buys or sells EBS shares.

Notify only if

News

Receive news related to Emergent BioSolutions Inc.

Track Activities on EBS